The current role of immuno-oncology in AML and future outlooks

Immuno-oncology: what is next for AML?Подробнее

The future of immuno-oncologyПодробнее

Monoclonal antibodies in AML - current and future outlooksПодробнее

What is Immuno-oncology?Подробнее

Future role of CAR-T in AMLПодробнее

Current concepts and future developments in T-cell-based immunotherapy of AMLПодробнее

Future treatment strategies for R/R Ph+ ALLПодробнее

Immuno-Oncology: A Future LookПодробнее

T-cell bispecifics in AML: ongoing challenges and future outlooksПодробнее

Future prospects for CAR-T cell therapy in AMLПодробнее

Maintenance therapy in AML: agents under investigation and future outlooksПодробнее

What is the future of immunotherapy in AML? #AMLПодробнее

Targeted therapy for AML: current outlook and future potentialПодробнее

The current role of MRD in CLL and future outlooksПодробнее

The Future of Immuno-OncologyПодробнее

Key targets and the future of immunotherapy in AMLПодробнее

The current guidelines and therapies for TP53-mutated MDS and AMLПодробнее

Improving transplantation outcomes in patients with active AML: current approaches & future outlooksПодробнее

The Current & Future Wave of Immuno-Oncology TherapiesПодробнее